Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.74 CHF | -0.51% |
|
-1.18% | -50.78% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 264M 304M 246M 226M 426M 29.06B 434M 2.91B 1.14B 14.43B 1.14B 1.12B 48.53B | P/E 2026 * |
-9.36x | P/E 2027 * | 34.3x |
|---|---|---|---|---|---|
| Enterprise Value | 303M 349M 281M 260M 489M 33.31B 498M 3.33B 1.3B 16.54B 1.31B 1.28B 55.63B | EV / Sales 2026 * |
27.9x | EV / Sales 2027 * | 6.23x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | -0.59% | ||
| 1 week | -1.18% | ||
| Current month | -9.97% | ||
| 1 month | -5.32% | ||
| 3 months | -14.93% | ||
| 6 months | -41.30% | ||
| Current year | -50.78% |
| 1 week | 11.48 |  | 12.32 |
| 1 month | 11.24 | | 13.02 |
| Current year | 11.24 | | 31.85 |
| 1 year | 6.62 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/3/25 | Fiscal year | Founder | 5,465 | 0.0274% | ||
| 12/3/25 | Sell | 5,465 | 0.0274% | |||
| 11/27/25 | Fiscal year | Founder | 14,567 | 0.0730% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -1.18% | +70.39% | +125.77% | 304M | |
| -0.95% | +3.39% | -0.94% | +12.15% | 49.37B | |
| -2.56% | +12.30% | +25.70% | +4.41% | 39.14B | |
| -1.80% | -0.80% | +403.69% | +615.14% | 40.85B | |
| -2.54% | -3.95% | +3.95% | +46.12% | 35.81B | |
| -1.74% | +8.42% | +8.85% | +48.87% | 30.5B | |
| -2.41% | -3.43% | - | - | 16.55B | |
| -1.67% | -5.18% | +33.48% | +125.23% | 16.14B | |
| -1.52% | -1.35% | -3.35% | -34.96% | 12.77B | |
| -0.06% | +3.31% | +1.90% | +9.62% | 13.71B | |
| Average | -1.58% | +4.74% | +60.41% | +105.82% | 25.52B | |
| Weighted average by Cap. | -1.76% | +6.70% | +77.15% | +129.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.48M 10.07M 9.29M 17.49M 1.19B 17.81M 119M 46.67M 592M 46.88M 45.85M 1.99B | 44.83M 51.61M 41.63M 38.39M 72.32M 4.93B 73.63M 493M 193M 2.45B 194M 190M 8.23B |
| Net income | -31.17M -35.89M -28.95M -26.7M -50.29M -3.43B -51.2M -343M -134M -1.7B -135M -132M -5.72B | 5.02M 5.78M 4.66M 4.3M 8.1M 552M 8.25M 55.22M 21.62M 274M 21.72M 21.24M 922M |
| Net Debt | 38.68M 44.54M 35.92M 33.13M 62.4M 4.25B 63.54M 425M 167M 2.11B 167M 164M 7.1B | 14.72M 16.94M 13.67M 12.6M 23.74M 1.62B 24.17M 162M 63.35M 803M 63.63M 62.23M 2.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | CHF 11.74 | -0.51% | 28,420 |
| 26-07-30 | CHF 11.80 | +2.25% | 40,096 |
| 26-07-29 | CHF 11.54 | -4.15% | 131,713 |
| 26-07-28 | CHF 12.04 | +0.67% | 28,051 |
| 26-07-27 | CHF 11.96 | +0.67% | 17,833 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
